CARGO Therapeutics Appoints Biotech Life Sciences Leaders to Board of Directors tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Suspending development of ATRC-101 Cost-saving measures include 40% workforce reduction Focusing on advancing earlier stage ADC candidates and preserving discovery capabilities SAN CARLOS, Calif.,. -Today at 04:07 pm- MarketScreener
Operator: Thank you for standing by. Welcome to the Atreca s Fourth Quarter and Year End 2022 Earnings Call. At this time, all participants are in a listen-only mode.
ATRC-101 continues to be well tolerated in ongoing Phase 1b trial; clinical activity observed in multiple tumor types; longer progression free survival observed in patients with high target expression. | March 29, 2023
29.03.2023 - ATRC-101 continues to be well tolerated in ongoing Phase 1b trial; clinical activity observed in multiple tumor types; longer progression free survival observed in patients with high target expression Phase 2 go/no-go decisions for ATRC-101 .